Skip to content
OpenCapital
Get started

Ooma OOMA Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
Ooma Business70%+12.9%
Ooma Residential28%-20.0%

Other financials

Income statement

See full
Revenue$81.1M+24.8%
Gross profit$50.7M+26.0%
Operating income$3.5M+6,254%
Net income$2.6M+1,931%
EPS (diluted)$0.09+1,000%

Balance sheet

See full
Cash & equivalents$17.2M-9.6%
Total debt$67.9M+335%
Total equity$95.9M+9.3%
Total assets$226.9M+52.5%

Cash flow

See full
Operating cash flow$6.4M+72.9%
CapEx$1.5M+20.3%
Free cash flow$4.9M+98.8%

Valuation

See full
Market cap$482.18M+42.5%
Enterprise value$532.92M+59.1%
P/E52.5×—
P/S1.7×+0.4×

Profitability

See full
Gross margin61.3%+0.4pp
Operating margin2.7%+2.0pp
Net margin3.2%+2.3pp
FCF margin8.5%+0.6pp

Returns & leverage

See full
Return on equity10%+7.3pp
Debt / equity0.7×+0.5×
Current ratio0.9×-0.2×